A novel formulation enabled transformation of 3-HIV drugs tenofovir–lamivudine–dolutegravir from short-acting to long-acting all-in-one injectable

Overview of attention for article published in AIDS, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 3 news outlets

twitter: 26 X users

Readers on

mendeley: 8 Mendeley

Summary News X

So far, Altmetric has seen 27 X posts from 26 X users, with an upper bound of 23,397 followers.

Guri Puerto Ordaz Maracaibo Una nueva formulación permitió la transformación de tres medicamentos contra el VIH, tenofovir-lamivudina-dolutegravir (TLD), de un inyectable todo en uno de acción corta a uno de acción prolongada https://t.co/nGRNHqfM4Y

01 Oct 2023

Reply Repost Favourite

RT @infeccHRUmalaga: NUEVA ADMINISTRACION fármacos #VIH➡️Tenofovir+ Lamivudina + Dolutegravir #SUBCUTANEO 1 vez al mes. Ensayo en primates🐒…

30 Sep 2023

Reply Repost Favourite

A novel formulation enabled transformation of 3 HIV drugs tenofovir-lamivudine-dolutegravir (TLD) from short-acting to long-acting all-in-one injectable https://t.co/Q1wdNrtLzW

29 Sep 2023

Reply Repost Favourite

RT @infeccHRUmalaga: NUEVA ADMINISTRACION fármacos #VIH➡️Tenofovir+ Lamivudina + Dolutegravir #SUBCUTANEO 1 vez al mes. Ensayo en primates🐒…

29 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 23 additional X posts.